Peter H. Andersen

2.4k total citations
47 papers, 2.1k citations indexed

About

Peter H. Andersen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter H. Andersen has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Cellular and Molecular Neuroscience and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter H. Andersen's work include Receptor Mechanisms and Signaling (21 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Peter H. Andersen is often cited by papers focused on Receptor Mechanisms and Signaling (21 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Peter H. Andersen collaborates with scholars based in Denmark, United States and United Kingdom. Peter H. Andersen's co-authors include Erik B. Nielsen, Claus Bræstrup, Frederik C. Grønvald, Jens Aas Jansen, Peter Bjerring, Annette G. Hansen, Lars J. S. Knutsen, Rolf Hohlweg, Peter D. Suzdak and Kristen Frederiksen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Reviews Drug Discovery and FEBS Letters.

In The Last Decade

Peter H. Andersen

47 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter H. Andersen Denmark 25 1.4k 1.1k 325 153 148 47 2.1k
Paul Van Gompel Belgium 15 1.3k 0.9× 895 0.8× 616 1.9× 105 0.7× 178 1.2× 26 2.1k
Patricia C. Contreras United States 30 1.4k 1.0× 1.5k 1.4× 176 0.5× 121 0.8× 197 1.3× 58 2.7k
J E Leysen Belgium 13 1.2k 0.9× 920 0.9× 282 0.9× 76 0.5× 208 1.4× 20 1.8k
Gene C. Palmer United States 27 1.2k 0.8× 1.0k 1.0× 349 1.1× 166 1.1× 337 2.3× 112 2.2k
Cristina Cosi France 27 1.1k 0.8× 939 0.9× 200 0.6× 168 1.1× 223 1.5× 51 2.1k
S.Z. Langer France 20 1.5k 1.0× 1.1k 1.1× 200 0.6× 158 1.0× 270 1.8× 47 2.1k
R J Baldessarini United States 28 946 0.7× 746 0.7× 566 1.7× 195 1.3× 246 1.7× 62 2.1k
Jean‐Paul Nicolas France 22 929 0.7× 834 0.8× 175 0.5× 120 0.8× 152 1.0× 30 1.8k
T. Lee Canada 5 1.0k 0.7× 703 0.7× 554 1.7× 140 0.9× 99 0.7× 5 1.6k
Albert Sattin United States 22 1.0k 0.7× 792 0.7× 202 0.6× 93 0.6× 243 1.6× 61 2.0k

Countries citing papers authored by Peter H. Andersen

Since Specialization
Citations

This map shows the geographic impact of Peter H. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Andersen more than expected).

Fields of papers citing papers by Peter H. Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Andersen. The network helps show where Peter H. Andersen may publish in the future.

Co-authorship network of co-authors of Peter H. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Andersen. A scholar is included among the top collaborators of Peter H. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Andersen. Peter H. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larsen, Anna Kirstine, Lise T. Brennum, Jan Egebjerg, et al.. (2004). Selectivity of 3H‐MADAM binding to 5‐hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects. British Journal of Pharmacology. 141(6). 1015–1023. 23 indexed citations
2.
3.
Ankersen, Michael, Nils L. Johansen, Kjeld Madsen, et al.. (1998). A New Series of Highly Potent Growth Hormone-Releasing Peptides Derived from Ipamorelin. Journal of Medicinal Chemistry. 41(19). 3699–3704. 27 indexed citations
4.
Hall, Randy A., Annette G. Hansen, Peter H. Andersen, & Thomas R. Soderling. (1997). Surface Expression of the AMPA Receptor Subunits GluR1, GluR2, and GluR4 in Stably Transfected Baby Hamster Kidney Cells. Journal of Neurochemistry. 68(2). 625–630. 58 indexed citations
5.
Andersen, Peter H., et al.. (1996). Stable expression of homomeric AMPA-selective glutamate receptors in BHK cells. European Journal of Pharmacology. 311(1). 95–100. 21 indexed citations
6.
Jørgensen, Marianne Hørby, et al.. (1995). Ionotropic Glutamate Receptors – Focus on Non‐NMDA Receptors. Pharmacology & Toxicology. 76(5). 312–319. 18 indexed citations
7.
Jørgensen, Marianne Hørby, et al.. (1995). The importance of two specific domains in ligand binding to the AMPA/kainate glutamate receptors GluR2 and GluR6. FEBS Letters. 363(1-2). 184–188. 16 indexed citations
8.
Jensen, Anders A., et al.. (1994). Characteristics of stably expressed human dopamine D1a and D1b receptors: Atypical behavior of the dopamine D1b receptor. European Journal of Pharmacology Molecular Pharmacology. 267(1). 85–93. 24 indexed citations
9.
Nielsen, Erik B. & Peter H. Andersen. (1992). Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists. European Journal of Pharmacology. 219(1). 35–44. 38 indexed citations
10.
Andersen, Peter H., et al.. (1992). NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. European Journal of Pharmacology. 219(1). 45–52. 74 indexed citations
11.
Bræstrup, Claus, Erik B. Nielsen, Ursula Sonnewald, et al.. (1990). (R)‐N‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier. Journal of Neurochemistry. 54(2). 639–647. 196 indexed citations
12.
Bræstrup, C. & Peter H. Andersen. (1989). Receptor Subtypes and Endogenous Ligands: Rational Tools in the Search for Psychotropic Drugs. PubMed. 7. 3–9. 1 indexed citations
13.
Nielsen, Erik B., et al.. (1989). Amphetamine discrimination: effects of dopamine receptor agonists. European Journal of Pharmacology. 160(2). 253–262. 44 indexed citations
14.
Andersen, Peter H.. (1989). The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. European Journal of Pharmacology. 166(3). 493–504. 313 indexed citations
15.
Treiman, Marek & Peter H. Andersen. (1989). Two Classes of [3H]Spiperone Binding Sites in Bovine Neurohypophysis: D-2 Receptors and Putative 5-Ht2Receptors. Journal of Receptor Research. 9(4-5). 297–312. 3 indexed citations
16.
Ternowitz, T., Peter H. Andersen, Peter Bjerring, et al.. (1989). 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response. Archives of Dermatological Research. 281(6). 401–405. 16 indexed citations
17.
Andersen, Peter H.. (1988). Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain. European Journal of Pharmacology. 146(1). 113–120. 99 indexed citations
18.
Andersen, Peter H. & Mogens Brøndsted Nielsen. (1987). Irradiation inactivation studies of the dopamine D1 receptor and dopamine-stimulated adenylate cyclase in rat striatum. Neuroscience Letters. 83(1-2). 167–172. 1 indexed citations
19.
Andersen, Peter H., et al.. (1987). Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists. European Journal of Pharmacology. 137(2-3). 291–292. 45 indexed citations
20.
Andersen, Peter H. & Arne Geisler. (1984). Lithium Inhibition of Forskolin-Stimulated Adenylate Cyclase. Neuropsychobiology. 12(1). 1–3. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Van Gompel Breakdown of academic impact, for papers by Patricia C. Contreras Breakdown of academic impact, for papers by J E Leysen Breakdown of academic impact, for papers by Gene C. Palmer Breakdown of academic impact, for papers by Cristina Cosi Breakdown of academic impact, for papers by S.Z. Langer Breakdown of academic impact, for papers by R J Baldessarini Breakdown of academic impact, for papers by Jean‐Paul Nicolas Breakdown of academic impact, for papers by T. Lee Breakdown of academic impact, for papers by Albert Sattin
Rankless by CCL
2026